This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Stroke and HRT

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In the Women's Health Initiative study there was a relative risk 1.41 at 5.2 years of the development of a stroke (comparing oestrogen plus progestogen arm vs. placebo group) (1) - this meant an increased absolute risk of 8 per 10,000 women per year.

NICE state with respect risk of stroke with HRT (2):

Explain to women that taking oral (but not transdermal) oestrogen is associated with a small increase in the risk of stroke

  • the baseline population risk of stroke in women aged under 60 years is very low

  • Table: Absolute rates of stroke for different types of HRT compared with no HRT (or placebo), different durations of HRT use and time since stopping HRT for menopausal women
    • difference in stroke incidence per 1000 menopausal women over 7.5 years (95% confifidence interval) (baseline population risk in the UK over 7.5 years: 11.3 per 1000

Current HRT users

Treatment duration <5 years

Treatment duration 5-10 years

>5 years since stopping treatment

Women on oestrogen alone

RCT estimate

0 (-5 to 10)

No available data

No available data

1 more (-4 to 9)

Women on oestrogen alone

Observational estimate

3 more (-1 to 8)

No available data

No available data

No available data

Women on oestrogen + progestogen

RCT estimate

6 more (-2 to 21)

No available data

No available data

4 more (-1 to 13)

Women on oestrogen + progestogen

Observational estimate

4 more (1 to 7)

No available data

No available data

No available data

Reference:

  1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results for the Women's Health Initiative Randomized controlled trial. JAMA 2002; 288:321-333.
  2. NICE (November 2015). Menopause: diagnosis and management

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.